Search
for

    Sort by

    Research 91–120 of 159

    1. Contents Vol. 2, 2016 Skin appendage disorders · 2016
    2. Alopecias Springer eBooks · 2015
    3. Index 2013
    4. Table of Contents 2012
    5. Síndrome PRIDE: una práctica forma de identificar los efectos adversos cutáneos de los inhibidores del EGFR Revista Medicina Cutánea Ibero-Latino-Americana · 2021
    6. Epidermal Growth Factor Receptor Inhibitor–Induced Symmetrical Drug-Related Intertriginous and Flexural Exanthema: Should You Discontinue the Offending Agent? Cutis · 2023 · 1 citations
    7. Bimatoprost Topical Journal of the Dermatology Nurses' Association · 2017
    8. The Cutaneous Epidermal Growth Factor Network: Can it be Translated Clinically to Stimulate Hair Growth? Dermatology Online Journal · 2009 · 39 citations
    9. Taiwanese Dermatological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities Journal of the Formosan Medical Association · 2017 · 22 citations
    10. Erlotinib-Associated Alopecia in a Lung Cancer Patient Journal of Thoracic Oncology · 2007 · 8 citations
    11. Alopecia and Hair Damage Induced by Oncological Therapy Klinická onkologie · 2019 · 7 citations
    12. Loose anchoring of anagen hairs and pili torti due to erlotinib International Journal of Trichology · 2016 · 5 citations
    13. Epidermal growth factor receptor inhibitors and hair Journal of the American Academy of Dermatology · 2008 · 4 citations
    14. Dystrophic-Anagen Effluvium Occurring During Pegylated Interferon-α-2a/Ribavirin Therapy Hepatitis Monthly · 2015 · 2 citations
    15. Continuous MEK inhibition by AZD6244 (ARRY-142886) results in exhaustion of the cutaneous keratinocytic stem cell pool and resembles senescence driven skin aging Journal of Clinical Oncology · 2008 · 2 citations
    16. Dermatological Manifestations of Pegylated Interferon alfa2a and Ribavirin Combination Therapy in Chronic HCV Patients Afro-Egyptian Journal of Infectious and Endemic Diseases · 2016
    17. Hypertrichosis and Hyperpigmentation in the Periocular Area Associated with Travoprost Treatment 2015
    18. The Cutaneous Epidermal Growth Factor Network: Can it be Translated Clinically to Stimulate Hair Growth? - eScholarship Dermatology Online Journal · 2009
    19. Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management Clinical Reviews in Allergy & Immunology · 2021 · 290 citations
    20. Understanding, recognizing, and managing toxicities of targeted anticancer therapies Ca · 2013 · 278 citations
    21. Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails American Journal of Clinical Dermatology · 2018 · 179 citations
    22. Androgenetic Alopecia: An Update of Treatment Options Drugs · 2016 · 110 citations
    23. Genome-wide association meta-analysis of individuals of European ancestry identifies new loci explaining a substantial fraction of hair color variation and heritability Nature Genetics · 2018 · 94 citations
    24. Bimatoprost in the treatment of eyelash hypotrichosis Clinical ophthalmology · 2010 · 69 citations
    25. Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management Dermatology research and practice · 2014 · 68 citations
    26. The biology and genetics of curly hair Experimental Dermatology · 2017 · 65 citations
    27. A Review of Adverse Cutaneous Drug Reactions Resulting from the Use of Interferon and Ribavirin Canadian Journal of Gastroenterology · 2009 · 64 citations
    28. Poliosis circumscripta: Overview and underlying causes Journal of the American Academy of Dermatology · 2013 · 44 citations
    29. Exploring the possibility of predicting human head hair greying from DNA using whole-exome and targeted NGS data BMC Genomics · 2020 · 37 citations
    30. EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management Oncology and therapy · 2017 · 29 citations